Silent Threat of the Coronavirus: America’s Dependence on Chinese Pharmaceuticals
By Christine Crudo Blackburn, Andrew Natsios Gerald W Parker and Leslie Ruyle
As the new coronavirus, called 2019-nCoV, spreads rapidly around the globe, the international community is scrambling to keep up. Scientists rush to develop a vaccine, policymakers debate the most effective containment methods, and health care systems strain to accommodate the growing number of sick and dying. Though it may sound like a scene from the 2011 movie "Contagion," it is actually an unfolding reality.
In the midst of all of this, a potential crisis simmers in the shadows: The global dependence on China for the production of pharmaceuticals and medical equipment.
Chinese Dominance in the Pharmaceutical Market
We represent an interdisciplinary group of scientists and policymakers at the Scowcroft Institute's Pandemic and Biosecurity Policy Program based at the Bush School of Government at Texas A&M University who have been holding annual summits addressing pandemic-related issues for the past five years. One of our goals is to promote dialogue on potential risks related to pandemics and U.S. security, in this case the disruption of supply chains and availability of medical supplies and drugs.
Today, about 80% of pharmaceuticals sold in the U.S. are produced in China. This number, while concerning, hides an even greater problem: China is the largest and sometimes only global supplier for the active ingredient of some vital medications. The active ingredients for medicines that treat breast cancer and lung cancer and the antibiotic Vancomycin, which is a last resort antibiotic for some types of antimicrobial resistant infections, are made almost exclusively in China. Additionally, China controls such a large market portion of heparin, a blood thinner used in open-heart surgery, kidney dialysis and blood transfusions that the U.S. government was left with no choice but to continue buying from China even after a contamination scandal in 2007.
China is not only the dominant global supplier of pharmaceuticals, but it is also the largest supplier of medical devices in the U.S. These include things like MRI equipment, surgical gowns, and equipment that measures oxygen levels in the blood. Supplies of these essential products have not yet been severely disrupted by the coronavirus, but if China is no longer will or able to supply them to the U.S., thousands of Americans could die.
More concerning still are the limited options available to the U.S. and the rest of the globe to make up the shortfall. It could take years to develop the necessary infrastructure to reestablish U.S. manufacturing capacities and obtain Food and Drug Administration licensure to overcome the loss of the Chinese supply.
When a disease reaches epidemic levels, the first obligation for leaders in any country is to protect their own people. As this current crisis progresses, there may come a point when political leaders in China will face decisions on whether to prohibit the export of pharmaceuticals, medical devices and other vital medical components in order to treat or protect their own people. Such acts would be the logical outcome of an escalating situation. For the 2009 H1N1 pandemic response, for example, the U.S. was pushed to the back of the queue for vaccine deliveries even though we had existing contracts with a major vaccine manufacturer located in another country. Those vaccine deliveries were delayed.
Disruption of Global Pharmaceuticals?
While a total loss of active ingredient imports from China might seem far-fetched, we believe the increasing scale of the outbreak moves it closer to the realm of possibility.
About six weeks into international recognition of the epidemic in China, there are already shortages of vital personal protective equipment in both China and the U.S. UPS has transported more than 2 million masks and 11,000 gowns to Wuhan to help alleviate the shortage. But what happens when everyone runs out of protective equipment?
Wuhan is a significant player in the biotechnology and pharmaceutical industry, with multiple pharmaceutical companies located in the city. How many of these factories have closed as a result of the pandemic, and when will those that have closed open back up? Global supply chains could reach a crisis point if they are compromised because Hubei province, where Wuhan is located, is in quarantine and factories are shut down.
Additionally, Wuhan is the location of China's first Biosafety Level (BSL) 4 laboratory, which was opened in 2017 to research SARS and other emerging diseases. It is the only lab in China that can safely handle the world's most dangerous pathogens that pose a significant risk of transmission. Infection, death and quarantine in Wuhan and the surrounding Hubei province is restricting the ability of all types of commerce in the region. Meanwhile, the virus is already creating a significant supply chain imbalance within China. That means those medical supply companies will be under pressure to keep any products produced within the country for protection of their own health care workers, laboratory personnel and the general public.
The regulatory apparatus to insure that the Chinese manufactured pharmaceuticals being exported meet the highest standards of safety and quality control are weak or nonexistent, according to a congressional report last year. The pressure placed on supply chains by the outbreak could further exacerbate existing quality control challenges. In doing so, the virus has highlighted our reliance on China as a U.S. national security issue due to outsourcing our manufacturing capabilities and inability to ensure quality control.
As with all pandemics, the complexity of this outbreak demands international collaboration and transparency. At the same time, U.S. public health officials must acknowledge the country's vulnerability due to our dependence on Chinese production of pharmaceuticals and medical equipment. The U.S. must develop a response plan for the inevitable shortages in the near-term and take necessary actions to reclaim control of our medical supply chain. Continuing to overlook this long-known vulnerability will only lead to catastrophe.
Christine Crudo Blackburn is a postdoctoral research fellow at the Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University.
Andrew Natsios is the director of the Scowcroft Institute of International Affairs and Executive Professor, Texas A&M University.
Gerald W Parker is the associate dean for Global One Health, College of Veterinary Medicine & Biomedical Sciences; and the Director for the Pandemic and Biosecurity Policy Program, Scowcroft Institute for International Affairs, Bush School of Government and Public Service, Texas A&M University.
Leslie Ruyle is the assistant director at the Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University.
Disclosure statement: Andrew Natsios is affiliated with the Bush School of Government, The Hudson Institute, Scowcroft Institute at the Bush School of Government at Texas A&M Univ, and Fio Corp.
Christine Crudo Blackburn, Gerald W Parker, and Leslie Ruyle do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.
Reposted with permission from The Conversation.
EcoWatch Daily Newsletter
When Europeans first arrived in North America, Atlantic puffins were common on islands in the Gulf of Maine. But hunters killed many of the birds for food or for feathers to adorn ladies' hats. By the 1800s, the population in Maine had plummeted.
- Experts Recommend Halving Global Fishing for Crucial Prey Species ›
- US Court Upholds Ruling on Vast Marine Monument Established by ... ›
A "major" natural gas explosion killed two people and seriously injured at least seven in Baltimore, Maryland Monday morning.
- Fatal Natural Gas Explosion Rocks Durham, NC - EcoWatch ›
- Gas Explosion Rips Through Maryland Office & Shopping Complex ... ›
Nearly 900 people across the U.S. and Canada have been sickened by salmonella linked to onions distributed by Thomson International, the The New York Times reported.
- Meat Producers Issue Massive Recalls after Salmonella, Listeria ... ›
- Salmonella Outbreaks Could Worsen with Decreased Poultry ... ›
- Major Salmonella Outbreak Exacerbated by Government Shutdown ... ›
In the coming days, the U.S. Environmental Protection Agency (EPA) is expected to use its power to roll back yet another Obama-era environmental protection meant to curb air pollution and slow the climate crisis.
- Permian Basin Methane Emissions Found to Be More Than 2x ... ›
- Oil and Gas Operations Release 60 Percent More Methane than ... ›
- 'Extraordinarily Harmful' Trump Rule Would Gut Restrictions on ... ›
- Exxon Now Wants to Write the Rules for Regulating Methane ... ›
By Alex Kirby
The temperature of the Arctic matters to the entire world: it helps to keep the global climate fairly cool. Scientists now say that by 2035 there could be an end to Arctic sea ice.
Melt Ponds Crucial<p>"The prospect of loss of sea ice by 2035 should really be focusing all our minds on achieving a low-carbon world as soon as humanly feasible."</p><p><a href="http://www.reading.ac.uk/search/search-staff-details.aspx?id=10813" target="_blank">Dr. David Schroeder from the University of Reading</a>, UK, who co-led the implementation of the melt pond scheme in the climate model, says, "This shows just how important sea ice processes like melt ponds are in the Arctic, and why it is crucial that they are incorporated into climate models."</p><p>The extent of the areas <a href="https://nsidc.org/cryosphere/seaice/characteristics/formation.html" target="_blank">sea ice</a> covers varies between summer and winter. If more solar energy is absorbed at the surface, and temperatures rise further, a cycle of warming and melting occurs during summer months.</p><p>When the ice forms, the ocean water beneath becomes saltier and denser than the surrounding ocean. Saltier water sinks and moves along the ocean bottom towards the equator, while warm water from mid-depths to the surface travels from the equator towards the poles.</p><p>Scientists refer to this process as the ocean's global "conveyor-belt." Changes to the volume of sea ice can disrupt normal ocean circulation, with consequences for global climate. </p>
- Strongest, Oldest Arctic Sea Ice Breaks Up for First Time on Record ... ›
- Arctic Sea Ice Levels Hit Record Low After Unusually Warm January ... ›
- Why California Droughts Could Increase Due to Arctic Sea Ice Loss ... ›
Russia's Health Ministry has given regulatory approval for the world's first COVID-19 vaccine after less than two months of human testing, President Vladimir Putin said on Tuesday.
Putin's Daughter Among Vaccinated<p>The Russian leader also said that one of his daughters has already been inoculated and is feeling well.</p><p>"One of my daughters got vaccinated, so in this sense, she took part in the testing," Putin said.</p><p>After the first vaccine shot, his daughter experienced a slight fever, 38 degrees Celsius (100.4°F). Her temperature came down to just slightly above normal the next day. </p><p>"After the second shot, she had a slight fever again, and then everything was fine. She is feeling well and has a high antibody count," Putin said. </p><p>He didn't specify which of his two daughters, Maria or Katerina, received the vaccine.</p><p>Russian health authorities have said that medical workers, teachers and other risk groups will be the first to receive shots of the vaccine.</p>
Years of Work Reduced to Weeks<p>Russia is the first country to register a COVID-19 vaccine. As <a href="https://www.dw.com/en/germany-coronavirus-vaccine-may-only-be-available-in-mid-2021/a-54362065" target="_blank">countries worldwide race to produce the first vaccine</a>, health experts warn that speed and national pride could compromise safety.</p><p>Scientists in Russia and abroad have questioned Moscow's decision to register the vaccine before Phase 3 trials that normally last for months and involve thousands of people, but Putin emphasized that the vaccine underwent the necessary trials and that vaccination will be voluntary.</p><p>Russian officials have said that large-scale production of the vaccine will begin in September, and mass vaccination may start as early as October.</p><p>Philippine President Rodrigo Duterte, meanwhile, has <a href="https://www.dw.com/en/philippines-duterte-volunteers-to-be-putins-russian-coronavirus-vaccine-guinea-pig/a-54523030" target="_blank">lauded Russia's efforts in developing the vaccine</a> and said that the Philippines is ready to work with Moscow on vaccine trials, supply and production. Duterte volunteered to "be the first they can experiment on."</p><p>"I will tell President Putin that I have huge trust in your studies in combating COVID and I believe that the vaccine that you have produced is really good for humanity," Duterte said, adding that he thinks Russia's vaccine will be ready for the Philippines by December.</p>
- Pfizer Coronavirus Vaccine Enters Phase 2 and 3 Clinical Trials ... ›
- Trump Administration Buys up Nearly All the World's Supply of ... ›
- First Trial of Moderna's Coronavirus Vaccine Produces Immune ... ›
A powerful series of thunderstorms roared across the Midwest on Monday, downing trees, damaging structures and knocking out power to more than a million people.